HALO Kronos AI forecast
A 30-trading-day price forecast for Halozyme Therapeutics Inc. (HALO) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Halozyme Therapeutics Inc. at $84.28 on 2026-12-08, −34.4% from the last close of $128.50 on 2026-10-27. Eight out of ten sampled paths end between $75.47 and $86.79, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of HALO
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $131.11 | $125.07 | $136.19 |
| 2026-11-10 | $106.10 | $74.82 | $116.05 |
| 2026-11-17 | $87.41 | $68.19 | $99.78 |
| 2026-11-24 | $83.54 | $70.47 | $90.37 |
| 2026-12-01 | $85.87 | $72.30 | $93.96 |
| 2026-12-08 | $84.28 | $75.47 | $86.79 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for HALO?
- Kronos AI's median forecast for HALO is $84.28 in 30 trading days, −34.4% from the last close, with a 10–90% range of $75.47 to $86.79.
- Is the HALO Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.